Ann Feeney, PhD
Professor Emeritus
Department of Immunology and Microbiology
Research Focus
Epigenetic, genetic and transcriptional control of B cell differentiation and B cell repertoire formation. A main focus of our lab is the molecular analysis of the epigenetic, genetic and transcriptional mechanisms which regulate accessibility of the V, D, and J immunoglobulin (Ig) gene segments for V(D)J recombination, and that regulate the differentiation of B cell progenitors. In our repertoire formation studies, we are elucidating the factors which influence the composition of the initial antibody repertoire. Although there are many V, D, and J genes at each locus, we have previously shown that different gene segments rearrange with quite different relative frequencies in pro-B cells in vivo. One of our goals is to understand the basis of this non-random gene utilization. Cutting edge technologies such as ChIP-seq, RNA-seq, deep sequencing of the antibody repertoire and CRISPR/Cas9 genome editing are utilized in our research. We are analyzing the chromatin modifications that accompany B cell differentiation in vivo in an effort to understand the mechanism of lineage-specific and stage-specific control of accessibility of Ig genes, as well as to understand the control of rearrangement on the level of individual genes. 3D-FISH and chromosome conformation capture (3C) and 4C are being used to study the changes in the 3-dimensional structure of the Igh and IgK loci. A related study is to determine which transcription factors control the changes in the epigenetic profile and in the 3-dimensional structure of the receptor loci at the developmental stage at which they undergo rearrangement. Other studies are aimed at elucidating the mechanism by which transcription factors control V(D)J rearrangement and B cell differentiation. We have identified regions with the epigenetic marks of enhancers within the VK portion of the IgK locus and the Vh portion of the Igh locus, and we use CRISPR/Cas9 technology to delete these novel enhancer-like regulatory elements in a cell line that we can induce to undergo IgK rearrangement, and also in mice. In addition, we deleted other key transcription factor binding sites, including those of the long-range looping protein CTCF, to determine what proteins are important in the proper folding of the rearranging IgK locus. We also study the epigenetic regulation of later steps in B cell differentiation.
Select Publications
-
Bhat, Khalid H.; Priyadarshi, Saurabh; Naiyer, Sarah; Qu, Xinyan; Farooq, Hammad; Kleiman, Eden; Xu, Jeffery; Lei, Xue; Cantillo, Jose F.; Wuerffel, Robert; Baumgarth, Nicole; Liang, Jie; Feeney, Ann J.; Kenter, Amy L. An Igh distal enhancer modulates antigen receptor diversity by determining locus conformation. 2023, 14, 1225.
-
Barajas-Mora, E Maurici M.; Feeney, Ann J. Enhancers within the Ig V Gene Region Orchestrate Chromatin Topology and Regulate V Gene Rearrangement Frequency to Shape the B Cell Receptor Repertoire Specificities. 2023, 211, 1613-1622.
-
Barajas-mora, E M.; Kleiman, Eden; Xu, Jeffrey; Carrico, Nancy C.; Lu, Hanbin; Oltz, Eugene M.; Murre, Cornelis; Feeney, Ann J. A B-Cell-Specific Enhancer Orchestrates Nuclear Architecture to Generate a Diverse Antigen Receptor Repertoire.. Molecular Cell 2019, 73, 48-60.e5.
View -
Kleiman, Eden; Loguercio, Salvatore; Feeney, Ann J. Epigenetic Enhancer Marks and Transcription Factor Binding Influence V? Gene Rearrangement in Pre-B Cells and Pro-B Cells. Frontiers in Immunology 2018, 9, 2074.
-
Kleiman, Eden; Jia, Haiqun; Loguercio, Salvatore; Su, Andrew I.; Feeney, Ann J. YY1 plays an essential role at all stages of B-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2016, 113, E3911-20.
-
Choi, Nancy M.; Loguercio, Salvatore; Verma-Gaur, Jiyoti; Degner, Stephanie C.; Torkamani, Ali; Su, Andrew I.; Oltz, Eugene M.; Artyomov, Maxim N.; Feeney, Ann J. Deep sequencing of the murine IgH repertoire reveals complex regulation of nonrandom V gene rearrangement frequencies.. Journal of Immunology 2013, 191, 2393-2402.
View